Wild and Natural Olive Branches

Matthew 5:17-19

Israel's Pfizer Vaccine - Tracker and News | The Jerusalem Post

www.jpost.com

  1. Bourla has received several honors from Israeli institutions in recognition of his support for Israel and his contributions to medicine.

  2. Movers and shakers in Israeli society.

  3. An open-access format for drug discovery is helping design medications at lower prices against potential viral threats to mankind.

  4. Pfizer announced that there would be shortages of Bicillin L-A last month. Bicillin L-A is a long-acting injectable antibiotic that is also known as penicillin G benzathine. 

  5. The company's shares fell 3.5% in volatile premarket trading on Monday as Pfizer said it would stop developing its therapy lotiglipron.

  6. Supply of the drug, Bicillin L-A, is expected to be exhausted by the end of this quarter, the company said in a letter to the US health regulator dated Monday.

  7. The COVID products drove Pfizer's revenue to record levels, topping $100 billion in 2022 and $80 billion in 2021.

  8. Every day, there are 40,000 migraine attacks in Israel. This new Pfizer treatment could help

  9. The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."

  10. Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.